Effects of intestinal electrical stimulation on intestinal dysrhythmia and symptoms in dogs.
The aim of this study was to investigate the effect of intestinal electrical stimulation on small intestinal dysrhythmia and motion sickness-like symptoms induced by vasopressin. Female dogs chronically implanted with two pairs of electrodes on jejunum serosa were used in a four-session study. Saline and vasopressin were infused in sessions 1 and 2, respectively. Sessions 3 and 4 were the same as session 2, except a long- or short-pulse intestinal electrical stimulation was applied on the proximal pair of electrodes. Intestinal slow waves and motion sickness-like symptoms were recorded in each session. Results were as follows. (1) Vasopressin induced intestinal dysrhythmia, uncoupling of slow waves, and vomiting and motion sickness-like symptoms (P < 0.05, ANOVA). (2) Intestinal electrical stimulation with long pulses, but not short pulses, was capable of preventing vasopressin-induced intestinal dysrhythmia. (3) Intestinal electrical stimulation with short pulses, but not long pulses, prevented vomiting and the motion sickness-like symptoms. It is concluded that vasopressin induces intestinal dysrhythmia. Long-pulse intestinal stimulation normalizes vasopressin-induced intestinal slow-wave abnormalities with no improvement in symptoms. Short-pulse stimulation prevents emetic symptoms induced by vasopressin but has no effect on slow waves. These data suggest different mechanisms involved with different methods of intestinal stimulation.
Liu
Jinsong
J
Division of Gastroenterology, University of Texas Medical Branch, Galveston, Texas 77555-0632, USA.
Wang
Lijie
L
Chen
J D Z
JD
D000818:Animals; D004285:Dogs; D004599:Electric Stimulation Therapy / Q000379:methods*; D004567:Electrodes, Implanted; D005260:Female; D007410:Intestinal Diseases / Q000139:chemically induced / Q000503:physiopathology* / Q000628:therapy; D009041:Motion Sickness / Q000139:chemically induced / Q000503:physiopathology* / Q000628:therapy*; D016065:Myoelectric Complex, Migrating / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000009:adverse effects*; D014667:Vasopressins / Q000009:adverse effects*
D014662:Vasoconstrictor Agents; D014667:Vasopressins